Abstract:Neurodegenerative diseases are closely related to inflammatory and autoimmune events, suggesting that the dysregulation of the immune system is a key pathological factor. Both multiple sclerosis (MS) and Alzheimer's disease (AD) are characterized by infiltrating immune cells, activated microglia, astrocyte proliferation, and neuronal damage. Moreover, MS and AD share a common pro-inflammatory signature, characterized by peripheral leukocyte activation and transmigration to the central nervous system (CNS). MS and AD are both characterized by the accumulation of activated neutrophils in the blood, leading to progressive impairment of the blood–brain barrier. Having migrated to the CNS during the early phases of MS and AD, neutrophils promote local inflammation that contributes to pathogenesis and clinical progression. The role of circulating T cells in MS is well-established, whereas the contribution of adaptive immunity to AD pathogenesis and progression is a more recent discovery. Even so, blocking the transmigration of T cells to the CNS can benefit both MS and AD patients, suggesting that common adaptive immunity mechanisms play a detrimental role in each disease. There is also growing evidence that regulatory T cells are beneficial during the initial stages of MS and AD, supporting the link between the modulatory immune compartments and these neurodegenerative disorders. The number of resting regulatory T cells declines in both diseases, indicating a common pathogenic mechanism involving the dysregulation of these cells, although their precise role in the control of neuroinflammation remains unclear. The modulation of leukocyte functions can benefit MS patients, so more insight into the role of peripheral immune cells may reveal new targets for pharmacological intervention in other neuroinflammatory and neurodegenerative diseases, including AD.

The Emerging Role of Central and Peripheral Immune Systems in Neurodegenerative Diseases

CNS and CNS Diseases in Relation to Their Immune System

Emergence of the brain-border immune niches and their contribution to the development of neurodegenerative diseases

Frontiers of Neurodegenerative Disease Treatment: Targeting Immune Cells in Brain Border Regions

Neuroimmune interactions and their roles in neurodegenerative diseases

The Role of T-lymphocytes in Central Nervous System Diseases

Meningeal Immunity and Neurological Diseases: New Approaches, New Insights

Cross-Talk of the CNS With Immune Cells and Functions in Health and Disease

The contribution of the peripheral immune system to neurodegeneration

Frontiers of neurodegeneration diseases treatment: Targeting immune cells in brain border regions

Neuroimmune Mechanisms Underlying Alzheimer's disease: Insights into central and peripheral immune cell crosstalk

New insight into neurological degeneration: Inflammatory cytokines and blood–brain barrier

The role of neuroinflammation in neurodegenerative diseases: current understanding and future therapeutic targets

New Insights into the Biological Roles of Immune Cells in Neural Stem Cells in Post-Traumatic Injury of the Central Nervous System

Immune regulation within the central nervous system

Peripheral inflammation and neurocognitive impairment: correlations, underlying mechanisms, and therapeutic implications

Revealing the mechanisms of blood-brain barrier in chronic neurodegenerative disease: an opportunity for therapeutic intervention

Neuroinflammation in Alzheimer's disease: insights from peripheral immune cells

Understanding immune microenvironment alterations in the brain to improve the diagnosis and treatment of diverse brain diseases

Common Peripheral Immunity Mechanisms in Multiple Sclerosis and Alzheimer's Disease

Immune mechanisms and shared immune targets in neurodegenerative diseases